Your browser doesn't support javascript.
loading
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Chang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil.
Afiliación
  • Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Section 4, Taiwan Boulevard, Xitun District, Taichung, Taiwan. geechen@gmail.com.
  • Lam DC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. geechen@gmail.com.
  • Tsai CM; Institute of Medicine and School of Medicine, Chung Shan Medical University, Taichung, Taiwan. geechen@gmail.com.
  • Chen YM; Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
  • Shih JY; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Aggarwal S; Department of Chest Medicine, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming Medical University, Taipei, Taiwan.
  • Wang S; National Taiwan University Hospital, Taipei, Taiwan.
  • Kim SW; Sir Ganga Ram Hospital Rajinder Nagar, New Delhi, India.
  • Kim YC; Beijing Cancer Hospital, Beijing, China.
  • Wahid I; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Li R; Chonnam National University, Hwasun Hospital, Jeonnam, Republic of Korea.
  • Lim DW; Beacon International Specialist Centre, Selangor, Malaysia.
  • Sriuranpong V; St Luke's Medical Center, Quezon City, Philippines.
  • Chan RT; National Cancer Centre, Singapore, Singapore.
  • Lorence RM; Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Pathumwan, Bangkok, Thailand.
  • Carriere P; Hong Kong Pacific Centre, Kowloon, Hong Kong, China.
  • Raabe C; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
  • Cseh A; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
  • Park K; Boehringer Ingelheim International GmbH, Ingelheim Am Rhein, Germany.
Int J Clin Oncol ; 26(5): 841-850, 2021 May.
Article en En | MEDLINE | ID: mdl-33783657
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Taiwán